The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And what happened was when they did that they found stronger connections between the neurons um and more anti-depressant like um behaviors which lasted 8 weeks as opposed to what we typically consider the duration for ketamine which is like you know around a week or maybe a little bit less.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
In the study that you guys were were talking about, the researchers found that basically you can boost a specific um signaling pathway in the brain, something called the ERK pathway, which can sustain the therapeutic window of ketamine so that it's much longer. And what they did is um basically they took mice and they combined ketamine with this drug called BCI which inhibits DUSP DUSP6 or something like that which uh elevates ERK activity and helps reinforce those neural connections in the hippocampus um which is where the brain remembers everything.